{"id":"https://openalex.org/W55384331","doi":"https://doi.org/10.1177/135965350901400114","title":"Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors","display_name":"Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W55384331","doi":"https://doi.org/10.1177/135965350901400114","mag":"55384331","pmid":"https://pubmed.ncbi.nlm.nih.gov/19320243"},"language":"en","primary_location":{"id":"doi:10.1177/135965350901400114","doi":"https://doi.org/10.1177/135965350901400114","is_oa":true,"landing_page_url":"https://doi.org/10.1177/135965350901400114","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350901400114","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W55384331"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350901400114","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027458645","display_name":"Lotke Tambuyzer","orcid":"https://orcid.org/0000-0002-1705-3753","observed_orcids":["https://orcid.org/0000-0002-1705-3753"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lotke Tambuyzer","raw_affiliation_strings":["Tibotec BVBA, Mechelen, Belgium","Tibotec BVBA, Mechelen, Belgium. ltambuyz@its.jnj.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Mechelen, Belgium","institution_ids":[]},{"raw_affiliation_string":"Tibotec BVBA, Mechelen, Belgium. ltambuyz@its.jnj.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053785909","display_name":"Hilde Azijn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hilde Azijn","raw_affiliation_strings":["Tibotec BVBA, Mechelen, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Mechelen, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111763075","display_name":"Laurence T. Rimsky","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laurence T Rimsky","raw_affiliation_strings":["Tibotec BVBA, Mechelen, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Mechelen, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015140638","display_name":"Johan Vingerhoets","orcid":"https://orcid.org/0000-0001-5939-9501","observed_orcids":["https://orcid.org/0000-0001-5939-9501"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johan Vingerhoets","raw_affiliation_strings":["Tibotec BVBA, Mechelen, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Mechelen, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003672837","display_name":"Pierre Lecocq","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pierre Lecocq","raw_affiliation_strings":["Virco BVBA, Mechelen, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virco BVBA, Mechelen, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064101498","display_name":"Guenter Kraus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guenter Kraus","raw_affiliation_strings":["Tibotec BVBA, Mechelen, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Mechelen, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034390644","display_name":"Gast\u00f3n Picchio","orcid":"https://orcid.org/0000-0003-0957-883X","observed_orcids":["https://orcid.org/0000-0003-0957-883X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gaston Picchio","raw_affiliation_strings":["Tibotec Inc., Yardley, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec Inc., Yardley, PA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025469164","display_name":"Marie\u2010Pierre de B\u00e9thune","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marie-Pierre de B\u00e9thune","raw_affiliation_strings":["Tibotec BVBA, Mechelen, Belgium","Tibotec Inc., Yardley, PA, USA","Virco BVBA, Mechelen, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec BVBA, Mechelen, Belgium","institution_ids":[]},{"raw_affiliation_string":"Tibotec Inc., Yardley, PA, USA","institution_ids":[]},{"raw_affiliation_string":"Virco BVBA, Mechelen, Belgium","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":null,"fwci":8.7725,"has_fulltext":true,"cited_by_count":93,"citation_normalized_percentile":{"value":0.98185041,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"14","issue":"1","first_page":"103","last_page":"109"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9520000219345093},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.8140000104904175},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.847000002861023},{"id":"https://openalex.org/keywords/resistance-associated-mutations","display_name":"resistance-associated mutations","score":0.9900000095367432},{"id":"https://openalex.org/keywords/reverse-transcriptase","display_name":"reverse transcriptase","score":0.8899999856948853},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.7620000243186951},{"id":"https://openalex.org/keywords/prevalence-of-resistance","display_name":"resistance prevalence","score":0.4950000047683716},{"id":"https://openalex.org/keywords/site-directed-mutants","display_name":"site-directed mutants","score":0.6439999938011169}],"concepts":[{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.8167857527732849},{"id":"https://openalex.org/C2909970146","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Nucleoside Reverse Transcriptase Inhibitor","level":5,"score":0.7374775409698486},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.7166388034820557},{"id":"https://openalex.org/C182707283","wikidata":"https://www.wikidata.org/wiki/Q7315622","display_name":"Resistance mutation","level":5,"score":0.6676599979400635},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.628177285194397},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5982239246368408},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5205905437469482},{"id":"https://openalex.org/C2779690655","wikidata":"https://www.wikidata.org/wiki/Q374232","display_name":"Lentivirus","level":4,"score":0.4963858723640442},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4064178764820099},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.22374257445335388},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.19174957275390625},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.16335517168045044},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15787562727928162},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.15661323070526123},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06032481789588928}],"mesh":[{"descriptor_ui":"D005787","descriptor_name":"Gene Frequency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D016297","descriptor_name":"Mutagenesis, Site-Directed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D054303","descriptor_name":"HIV Reverse Transcriptase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D054303","descriptor_name":"HIV Reverse Transcriptase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/135965350901400114","doi":"https://doi.org/10.1177/135965350901400114","is_oa":true,"landing_page_url":"https://doi.org/10.1177/135965350901400114","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350901400114","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},{"id":"pmid:19320243","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19320243","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1177/135965350901400114","doi":"https://doi.org/10.1177/135965350901400114","is_oa":true,"landing_page_url":"https://doi.org/10.1177/135965350901400114","pdf_url":"https://journals.sagepub.com/doi/pdf/10.1177/135965350901400114","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W55384331.pdf","grobid_xml":"https://content.openalex.org/works/W55384331.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W1480425134","https://openalex.org/W1503934268","https://openalex.org/W1603726506","https://openalex.org/W1606623928","https://openalex.org/W1964948559","https://openalex.org/W1969676506","https://openalex.org/W1970203571","https://openalex.org/W1971697544","https://openalex.org/W1980214158","https://openalex.org/W1988425281","https://openalex.org/W1988861859","https://openalex.org/W1989692384","https://openalex.org/W1995524674","https://openalex.org/W2004800530","https://openalex.org/W2020760853","https://openalex.org/W2030545030","https://openalex.org/W2047054871","https://openalex.org/W2053570554","https://openalex.org/W2057957357","https://openalex.org/W2062755299","https://openalex.org/W2063176659","https://openalex.org/W2068705423","https://openalex.org/W2072320892","https://openalex.org/W2074877586","https://openalex.org/W2079256899","https://openalex.org/W2086783015","https://openalex.org/W2099539543","https://openalex.org/W2107377540","https://openalex.org/W2108012383","https://openalex.org/W2108363553","https://openalex.org/W2109893413","https://openalex.org/W2115212891","https://openalex.org/W2117681036","https://openalex.org/W2124217674","https://openalex.org/W2141353064","https://openalex.org/W2143910776","https://openalex.org/W2145880283","https://openalex.org/W2164032557","https://openalex.org/W2166079348","https://openalex.org/W2167698825","https://openalex.org/W2170178664","https://openalex.org/W2172130850","https://openalex.org/W2322155078","https://openalex.org/W2399044306","https://openalex.org/W2916691697"],"related_works":["https://openalex.org/W941368190","https://openalex.org/W2005274373","https://openalex.org/W2067207486","https://openalex.org/W2101093607","https://openalex.org/W2107377540","https://openalex.org/W2108363553","https://openalex.org/W2108012383","https://openalex.org/W2342950203","https://openalex.org/W2047659850","https://openalex.org/W2146795191"],"abstract_inverted_index":{"BACKGROUND:":[0],"Non-nucleoside":[1],"reverse":[2,40],"transcriptase":[3],"inhibitors":[4],"(NNRTIs)":[5],"are":[6],"an":[7,100],"important":[8],"component":[9],"of":[10,19,33,49,69,80,89,103,122,190,215,224,236,262],"antiretroviral":[11],"therapy":[12],"for":[13,200],"HIV":[14],"type-1":[15],"(HIV-1)-infected":[16],"patients.":[17],"Development":[18],"NNRTI":[20,50,81,108,141,169,219,226,244,264],"resistance":[21,93,124,203,245],"can":[22,247],"lead":[23],"to":[24,44,85,94,125,129,185,195,211,218,250],"treatment":[25],"failure":[26],"and":[27,91,115,128,166,246,255],"is":[28,83],"conferred":[29],"by":[30,53],"the":[31,39,45,54,67,73,87,104,120,213,260],"presence":[32],"specific":[34],"resistance-associated":[35],"mutations":[36,237],"(RAMs)":[37],"in":[38,113,116,134,176,181,187,229,242,253,256],"transcriptase.":[41],"In":[42,138],"addition":[43],"widely":[46],"used":[47,249],"list":[48,79,223],"RAMs":[51,82,142,170,227],"provided":[52],"International":[55],"AIDS":[56],"Society-USA":[57],"HIV-1":[58,123,243,263],"Drug":[59],"Resistance":[60],"Mutation":[61],"Group,":[62],"which":[63],"were":[64,143,171],"identified":[65],"on":[66,107,119,259],"basis":[68],"clinical":[70,135,202],"experience":[71],"with":[72,111,178],"approved":[74,126],"NNRTIs,":[75],"a":[76,188,233,240],"more":[77],"comprehensive":[78,234],"needed":[84],"guide":[86,251],"study":[88,231],"baseline":[90],"emerging":[92],"new":[95],"NNRTIs.":[96],"METHODS:":[97],"We":[98],"conducted":[99],"extensive":[101],"review":[102],"existing":[105],"literature":[106],"resistance,":[109],"together":[110],"several":[112],"vitro":[114,254],"vivo":[117,257],"studies":[118],"mechanism":[121],"NNRTIs":[127,130],"formerly":[131],"or":[132,175],"currently":[133],"development.":[136],"RESULTS:":[137],"total,":[139],"44":[140,225],"identified.":[144],"These":[145,168],"included":[146],"V90I,":[147],"A98G,":[148],"L100I,":[149],"K1O1E/P/Q,":[150],"K103H/N/S/T,":[151],"V106A/I/M,":[152],"V108I,":[153],"E138G/K/Q,":[154],"V179D/E/F/G/I,":[155],"Y181C/I/V,":[156],"Y188C/H/L,":[157],"V189I,":[158],"G190A/C/E/Q/S,":[159],"H221Y,":[160],"P225H,":[161],"F227C/L,":[162],"M230I/L,":[163],"P236L,":[164],"K238N/T":[165],"Y318F.":[167],"observed,":[172],"either":[173],"alone":[174],"combination":[177],"others,":[179],"ranging":[180],"frequency":[182],"from":[183,207],"0.02%":[184],"56.96%":[186],"panel":[189],"101,679":[191],"NNRTI-resistant":[192],"isolates":[193],"submitted":[194],"Virco":[196],"BVBA":[197],"(Mechelen,":[198],"Belgium)":[199],"routine":[201],"testing.":[204],"Phenotypical":[205],"data":[206],"site-directed":[208],"mutants":[209],"helped":[210],"establish":[212],"contribution":[214],"each":[216],"mutation":[217],"resistance.":[220,265],"CONCLUSIONS:":[221],"The":[222],"compiled":[228],"this":[230],"provides":[232],"overview":[235],"that":[238],"play":[239],"role":[241],"be":[248],"further":[252],"research":[258],"mechanisms":[261]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2016-06-24T00:00:00"}